Navigation Links
M-POSSUM, an effective risk assessment system prior to operation
Date:10/9/2007

Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.

Numerous scoring systems currently exist for risk assessment, including the Glasgow Coma Scale (GCS), the Acute Physiology and Chronic Health Evaluation (APACHE), and the Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM). These scoring systems are important tools in deciding the course of treatment. The best known and most widely used scoring systems, APACHE and POSSUM, have limitations when applied to high-risk, general surgical patients. APACHE is best suited to intensive care patients, but requires 24 h of observation, and weighing tables for individual disease states. POSSUM, on the other hand, is limited by its somewhat subjective nature and incomplete evaluation of cardiac signs. They propose a modified POSSUM (M-POSSUM) as a reasonable, practical and objective scoring system that can be used across a broad disease spectrum in general surgery.

In contrast to APACHE and POSSUM, the present scoring system is based on GCS, APACHE, and POSSUM, and supplemented with the following indices: hepatic function (bilirubin), blood glucose level, gastrointestinal function and nutritional status (albumin). However, body temperature, heart rate, sodium and potassium, which are always normal preoperatively in general surgery, are not considered. To avoid repetition, the duration of operation, volume of intraoperative blood loss and surgery are considered as operative wound indices for a malignant tumor. M-POSSUM also takes blood pressure and electrocardiographic activity into consideration during anesthesia.

Through a study of a series of more than 200 patients, They show that M-POSSUM is more accurate than POSSUM and APACHE II in predicting postoperative morbidity and mortality. M-POSSUM therefore seems to be a better model for risk assessment. Further studies are now being carried out.


'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1901
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. Morning after pill effective up to five days after having unprotected sex
4. Distraction therapy found very effective in postoperative patients
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. TELITHROMYCIN - the proven effective new drug for cap
7. Foods Rich In Flavonoids Effective In Prevention Of Cough
8. Looking Towards More Effective Leukemia Treatment
9. Effectiveness of acupuncture for migraines
10. PA-824 drug effective against Tuberculosis
11. Milk Thistle Not An Effective Cure For Liver Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Oregon (PRWEB) , ... February 11, 2016 , ... ... campus participated in the American Osteopathic Association’s (AOA) Match Program Tuesday, February 9, ... Match Program places students into osteopathic graduate medical education positions across the country. ...
(Date:2/11/2016)... ... , ... The Journal of Pain Research has seen a significant ... data taken from the Scopus database (Elsevier B.V.) and is a measure of a ... journal over a three year period and also the importance of the journals where ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... has been gearing up for their simultaneous grand openings in March. All seven ... now that you’re probably wondering, is reversing diabetes possible? According to this 2011 ...
(Date:2/11/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased ... Study for Plans and Purchasers.” Executives from Intel Corp. and Providence Health & ... health benefits program Connected Care, will discuss the challenges they faced (and how ...
(Date:2/11/2016)... ... 2016 , ... PharmMD CEO Robert Yeager announced ... on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include ... data breaches for the Part D Star Rating improvement and Medication Therapy Management ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by ... and just seven days left to go, ALEX is said to be delivered to backers starting May ... ... ... Created by ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... , Feb. 11, 2016 PLAD, Inc. (OTC ... 2016 with sales exceeding company targets, are adding key ... their trademark from the United States Patent and Trademark ... , Chief Executive Officer of PLAD, Inc.  In January, ... Pennsylvania with two new customers, Cumberland ...
Breaking Medicine Technology: